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Abstract
OBJECTIVE: To comprehensively evaluate the effec-
tiveness of acupuncture as a treatment for fibromy-
algia syndrome.
METHODS: Two review authors independently se-
lected the trials for the Meta-analysis, assessed
their methodological quality and extracted rele-
vant data. A quality assessment was conducted ac-
cording to the Cochrane Review Handbook 5.0.
RevMan 5.0.20 software was used in the statistical
analysis.
RESULTS: A total of 523 trials were reviewed and 9
trials were selected for Meta-analysis. (a) Compared
acupuncture with sham acupuncture, there was a
significant difference in the visual analogue scale,
but no difference in the pressure pain threshold.
Additionally, and there was a difference in the fibro-
myalgia impact questionnaire and the multidisci-
plinary pain inventory after 4 weeks of treatment,
but no difference after 7 weeks of therapy. There
was no difference in the numerical rating scale in
weeks 3, 8 and 13. (b) Acupuncture versus drugs.
There were differences in the VAS after 20 days of
acupuncture and moxibustion treatment compar-
ing with the drug amitriptyline, and after 4 weeks
of acupuncture and moxibustion treatment com-
paring with the drug fluoxetine and amitriptyline.
There were also differences in the number of ten-
der points when comparing acupuncture with ami-
triptyline or fluoxetine. There was no difference in
total efficiency when comparing acupuncture with
amitriptyline after 4 weeks of treatment, but there
were differences between the two groups 45 days
after treatment. There were also differences in total
efficiency comparing acupuncture with fluoxetine,
and when comparing 4 weeks post-treatment of
acupuncture with a combination of amitriptyline,
oryzanol and vitamin B. (c) A comparison of acu-
puncture, drugs and exercise with drugs and exer-
cise showed PPT differences in months 3 and 6.
There was no difference between the two compari-
son groups after follow-up visits in months 12 and
24.
CONCLUSION: Compared with sham acupuncture,
there was not enough evidence to prove the effica-
cy of acupuncture therapy for the treatment of fi-
bromyalgia. Some evidence testified that the effec-
tiveness of acupuncture therapy for fibromyalgia
was superior to drugs; however, the included trials
were not of high quality or had high bias risks. Acu-
puncture combined with drugs and exercise could
increase pain thresholds in the short term, but
there is a need for higher quality randomized con-
trolled trials to further confirm this.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Fibromyalgia syndrome (FMS) is a non-joint rheuma-
tism, that clinically mainly manifests as diffused skele-
tal muscle pain and systemic symmetrical distributed
tender points,1 accompanied by symptoms such as fa-
tigue, depression, anxiety, dipsomania, headaches, dif-
fuse abdominal pain, and frequent micturition that se-
verely affect the patient's quality of life.2,3 To date,
there are no domestic epidemiology statistics for this
disorder. The American Rheumatism Association
(ARA) states that FMS is the third most common rheu-
matic disease, after rheumatoid arthritis (RA) and os-
teoarthritis (OA).4 The incidence of FMS is approxi-
mately 2%-4% with a female to male gender ratio of
approximately 9∶1.5-6 The predilection age focuses on
35-507 and the pathogenesis is not yet known.8-10 A
study indicated that kinship to patients with FMS
means a higher susceptibility, suggesting it is related to
both genes and environmental factors.11
The European League Against Rheumatism (EULAR)
currently regards the drug amitriptyline as the most ef-
fective for FMS treatment, but its side effects hinder its
use as a long-term therapeutic method. As an economi-
cal therapeutic method, however, acupuncture and
moxibustion have been used to treat pain syndrome for
more than 2000 years.12 Studies suggest that 60%-90%
of FMS patients use one or more complementary or al-
ternative therapeutic methods;13,14 of these 22% try acu-
puncture and moxibustion therapy.15 FMS therapeutic
guidelines moderately recommend acupuncture and
moxibustion as they may improve FMS symptoms.16,17
A systematic review and Meta-analysis can insure the
quality of a specialized-recommendation therapeutic
schedule that has superior clinical directive signifi-
cance. At present, China's clinical trials do not include
international systematic reviews15,18,19 on acupuncture
versus sham acupuncture interventions whose results
reveal no evidence verifying that acupuncture therapy
achieves better results than sham acupuncture. Similar-
ly, domestic systematic reviews20 that demonstrate that
interventions achieve better results than amitriptyline
in the treatment of FMS are not included in interna-
tional clinical trials.These reviews all had methodologi-
cal limitations and were published prior to 2010.
Hence, the current study thoroughly researched the
randomized and quasi-randomized controlled trials
both in China and abroad. On the basis of systematic
reviews, outcome indicators were chosen that objective-
ly reflected the clinical curative effect and presented
the overall evaluation for clinical efficacy of acupunc-
ture versus placebo and Western Medicine as well as
acupuncture comprehensive therapy.
METHODS
Eligibility criteria
The research type: the chosen trials were either ran-
domized controlled trials (RCT) or controlled clinical
trials (CCT). CCT did not comply strictly with the
random distribution method. For example, the distri-
bution was in accordance with admission sequence or
other not-genuine randomized methods. The language
was limited to Chinese and English.
The research objects: there were no limits to research
subjects' age, gender, treatment courses, or source. The
definite diagnostic criteria were in line with FMS diag-
nostic criteria established by the American College of
Rheumatology (ACR) in 1990.21
The intervention types: the treatment group received
acupuncture therapy (no limits in needle type, needle
size and needle amounts, acupoint prescriptions, oper-
ating techniques, needle retention time, and course of
treatment); the control groups received sham acupunc-
ture (nonpoints were stimulated and not stimulated on
the surface of the skin) or took Western Medicine (no
limits in type and dose). In addition, the treatment
group which received acupuncture combined with the
certain therapy and the control group with the same
certain therapy were both included. The acupuncture
therapy included filiform needle acupuncture, elec-
tro-acupuncture (EA), moxibustion, laser irradiation,
and point application.
The outcome indicators: the major outcome indicators
were a visual analogue scale (VAS), and a numerical rat-
ing scale (NRS). The minor outcome indicators were:
the number of tender points (TePsN), the pressure
pain threshold (PPT), the short-form health survey
(SF-36), the fibromyalgia impact questionnaire (FIQ),
the multidisciplinary pain inventory (MPI), and the to-
tal efficacy rate.
Information sources
Information was sourced by electronic retrieval from
Chinese databases such as China National Knowledge
Infrastructure Database (1979-2012), China Science
and Technology Journal Database (1989-2012), Wan-
fang Database (1998-2012), and from the English data-
bases PubMed (1966-2012), EMBASE (1980-2012)
and Cochrane Library (fourth issue, 2012). Data were
also manually retrieved by searching library back issues
and recently published literature not contained in the
above databases.
Search strategy
The Chinese search terms used were: 'acupuncture and
moxibustion', 'needling' and 'fibromyalgia'. The Eng-
lish search terms were: 'fibromyalgia', 'fibromyal*', and
'acupuncture'. The period searched was until March 1,
2012. The specific retrieval strategy was:
To locate FMS: #1 fibromyalgia [MeSH]; #2 fibromy-
al* [tw]; #3 OR/1-2.
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To locate acupuncture interventions: #4 acupuncture
[MeSH]; #5 acupuncture therapy [MeSH]; #6 acu-
puncture points [MeSH]; #7 body acupuncture [tw]; #
8 electroacupuncture [MeSH]; #9 electro-acupuncture
[tw]; #10 electrical acupuncture [tw]; #11 ear acupunc-
ture [MeSH]; #12 auricular acupuncture [tw]; #13
scalp acupuncture [tw]; #14 OR/4-13; #15 3 AND 14.
Data extraction
Two evaluators independently reviewed each study ti-
tle and abstract. After excluding studies that clearly did
not meet the inclusion criteria, the remaining trials
were read in full for further determination. The review-
ers cross-checked the test results and differences in
opinions were resolved by discussion or by third party
arbitration.
Risk of bias in individual studies
Following the quality assessment standard recommend-
ed by the Cochrane Review Handbook 5.0,22 the bias
risk assessment tool involved six aspects: (a) random
distribution method; (b) allocative decision conceal-
ment; (c) whether the research objects, therapeutic
plan operators, and those measuring the results were
blinded; (d) result integrity; (e) presenting the study
findings selectively; and (f) other bias resources. Each
research result was examined based on the above six as-
pects and judged as "YES" (low-degree bias), "NO"
(high-degree bias) or "unclear" (lacking relative infor-
mation or uncertain bias condition). Two evaluators
cross-verified the quality assessment results of the inclu-
sive trials and differences in opinions were resolved by
discussion or by third party arbitration.
Summary measures and synthesis of results
Data Meta-analysis was conducted using RevMan
5.0.20 software,23 Each chosen study was tested for het-
erogeneity, and was considered heterogeneous if P<0.1
or I2>50%. A fixed effect model was used if no statisti-
cal heterogeneity existed in each study; if heterogeneity
existed, its origin was established. If clinical or method-
ological heterogeneity did not exist, a random effect
model was employed. Descriptive analysis was used if
distinct clinical heterogeneity existed in each study.
Weighted mean difference (WMD) was used for con-
tinuous variables, relative risk (RR) for categorical vari-
ables, and a 95% confidence interval (CI) signified ev-
ery effect size, with P≤0.05 being judged to have a sta-
tistical significant meaning.
Risk of bias across studies and additional analyses
Subgroup analysis: to inspect the relationship between
acupuncture therapeutic efficacy and the therapeutic
course.
Sensitivity analysis: to check the stability of the results
and exclude lower-quality literature (unclear allocation
concealment) and trials with over 20% drop out rate.
Publication bias: applying RevMan software23 to evalu-
ate publication bias (over 10 trials at minimum).
Dealing with missing data: the trial author was contact-
ed when the mean or standard deviation was absent. If
the data remained unavailable, the standard deviation
was estimated through standard error, P-value, t-value,
or the mean was replaced with the median if the origi-
nal data was under a normal distribution.
RESULTS
Study selection
In total, 677 relevant articles were identified: 551 of
these met the inclusive criterion, and 126 duplicated ar-
ticles were excluded. Articles from Chinese journals in
English, non-English language literature, systematic re-
views, literature reviews, case reports, and specialists'
experience were excluded, leaving a total of 52 articles.
The full text of these was carefully reviewed with only
nine final articles being selected for Meta-analysis (rea-
sons for exclusion: 10 case observations, 10 repetitive
articles, seven non-randomized controlled trials, 15
other intervention models, and one without original
data). Data collection process as shown in Figure 1.
Study characteristics
Research type: of the nine final studies, six24-27,30,32 were
RCT and three28,29,31 were CCT.
Research object: of the nine articles, one29 did not men-
tion the patient source, four27,28,30,31 dealt with outpa-
tients and/or inpatients, and the remaining four24-26,32
studied recruited patients. All nine trials were in line
with the diagnostic criteria established by the ARA in
1990.
Research interventions: in the trial test groups, two
studies24,25 used EA, one31 used transcutaneous electrical
stimulation, one27 applied laser irradiation to acupunc-
ture points, one32 employed acupuncture combined
with antidepressant drugs and exercise, and the remain-
ing four treated with acupuncture. In the trial control
groups, three trials27,28,31 used amitriptyline, one29 used
fluoxetine, one30 used amitriptyline with the oryzanol
and vitamin B1, three24-26 used sham acupuncture, and
one32 used antidepressants with exercise (Table 1).
The selected acupuncture points: one trial25 chose the
points based on acupuncture and moxibustion litera-
ture, two trials27,28 adopted clinical experiences com-
bined with the theory of Chinese medicine point selec-
tion, and the others employed Chinese medical theory
point selection (Table 2).
Risk of bias within studies
Random allocation method: four trials24-26,32 used com-
puters to generate the random allocation sequence,
one30 used a random number table to generate the ran-
dom sequence, one used the ballots method,27 and the
others28,29,31 were randomized sequences according to
the date of attending the doctor.
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Allocation concealment: two trials24,26 used allocation
concealment and the others did not describe it.
Blinding method: two trials25,26 used blinding methods,
and the remainder did not describe whether they did.
Selective research report: one trial31 had a selective re-
search report bias risk, the report of a further trial29 was
not clearly depicted, and the other trials had no selec-
tive report bias.
Other bias sources: only one trial26 stated that it had no
other bias risk; the others did not determine whether
there were other bias sources. The specific bias analysis
of each test is shown in Figures 2 and 3.
Synthesis of results
Acupuncture vs sham acupuncture: evaluation of VAS
pain scale: One trial24 was included to contrast EA and
sham acupuncture groups based on the difference in
curative effect, using the VAS pain scale. After 3 weeks
of treatment, the measured outcomes showed that the
two groups had statistically significant VAS score differ-
ences [WMD=﹣13.89, 95% CI (﹣28.86,﹣0.92)].
PPT scale score: Martin DP et al 25 was included to
contrast EA and sham acupuncture groups based on
the difference in curative effect, using the PPT scale.
After 3 weeks of treatment, the measured outcomes
showed that the two groups had no statistically signifi-
cant PPT score differences [WMD=0.78, 95% CI
(0.01, 1.55)].
FIQ scale evaluation: one trial25 was included to con-
trast ordinary acupuncture and sham acupuncture
groups based on the difference in curative effect, using
the FIQ scale. After 4 weeks of treatment, the mea-
sured outcomes revealed that the two groups had statis-
tically significant FIQ scale differences [WMD=﹣7.40,
95% CI (﹣ 13.60, ﹣ 1.20)]. After 7 weeks of treat-
ment, the results showed that the two groups had no
statistically significant FIQ score differences [WMD=
﹣4.60, 95% CI (﹣10.65, 1.45)].
MPI scale evaluation: one trial25 was included to con-
trast ordinary acupuncture and sham acupuncture
groups based on the difference in curative effect, using
the MPI scale. After 4 weeks of treatment, the mea-
sured outcomes revealed that the two groups had statis-
tically significant MPI score differences [WMD=﹣7.40,
95% CI (﹣ 13.12, ﹣ 1.68)]. After 7 weeks of treat-
ment, the results showed that the two groups had no
statistically significant MPI score differences [WMD=
﹣4.10, 95% CI (﹣10.20, 2.00)].
NRS scale evaluation: two trials26a/b (a/b: one article in-
cludes two different trials) were included to contrast or-
dinary acupuncture and sham acupuncture groups
based on the difference in curative effect. An NRS
scale evaluation was employed in weeks 3, 8 and 13.
The combined results in week 3 revealed that the two
groups had no statistically significant NRS score differ-
ence [WMD=﹣ 1.06, 95% CI (﹣ 10.41, ﹣ 8.30),
Chi2=0.03, I2=0% ]. The combined results in week 8
showed the two groups had no statistically significant
Figure 1 Flow chart of report selection process
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NRS score differences [WMD=﹣6.80, 95% CI (﹣3.66,
17.25), Chi2=1.17, I2=15% ]. The combined results in
week 13 showed the two groups had no statistically sig-
nificant NRS score differences [WMD=4.19, 95% CI
(﹣6.86,15.24) Chi2= 0.75, I2=0%] (Figure 4).
Acupuncture versus drugs
VAS pain scale: all three included acupuncture versus
drugs trials27-29 used the VAS pain scale. Two of these
compared the efficacy of acupuncture with amitripty-
line: one27 of which measured the outcome on day 20
to reveal that the two groups had statistically signifi-
cant VAS score differences [WMD=﹣ 2.27, 95% CI
(﹣3.05, ﹣1.49)] and the other28 of which measured
the outcome in week 4 showing that the two groups
had statistically significant VAS score differences
[WMD=﹣17.10, 95% CI (﹣23.93, ﹣10.27)]. The
third trial29 compared the efficacy of acupuncture thera-
py with fluoxetine and measured the outcome in week
4 showing that the two groups had statistically signifi-
cant VAS score difference [WMD=﹣ 2.47, 95% CI
(﹣3.13,﹣1.81)] (Figure 5).
Evaluation of TePsN (the number of tender points)
Two included trials28,29 investigated TePsN, and a TeP-
sN tender point count was conducted after 4 weeks of
treatment in both. One trial28 compared acupuncture
with amitriptyline, and the result proved that the two
groups had statistically significant TePsN differences
[WMD=﹣4.00, 95% CI (﹣6.73,﹣1.27)]. The other
trial29 contrasted the efficacy of acupuncture therapy
with fluoxetine, and the result revealed that the two
groups had statistically significant TePsN differences
[WMD=﹣5.20, 95% CI (﹣7.78,﹣2.62)].
Evaluation of total efficiency: five trials28-30,31a/b investi-
gating total efficiency were included. Three trials28,31a/b
compared acupuncture with amitriptyline, one28 of
which measured the treatment outcome after 4 weeks
showing that the two groups had no statistically signifi-
cant differences in the case of total efficacy [RR=1.38,
95% CI (1.00, 1.91)]. The other two trials31a/b adopted
the same indicators of efficacy and measured the out-
Study
Deluze C
et al 199224
Martin DP
et al 200625
Harria RE
et al 2005a26
Harria RE
et al 2005b26
Wang CM
200827
Guo AS
et al 200528
Guo Y
et al 201029
Wang SP
et al 200230
Guo XJ
et al 2004a31
Guo XJ
et al 2004b31
Targino RA
et al 200832
Intervention
Experimental intervention
Electro-acupuncture (n=36)
Electro-acupuncture (n=25)
Traditional Chinese
acupuncture (n=25)
Traditional Chinese
acupuncture (n=25)
Traditional Chinese
acupuncture together with
acupoint laser irradiation
(n=28)
Traditional Chinese
acupuncture (n=19)
Electro-acupuncture
together with TDP (n=36)
Traditional Chinese
acupuncture (n=28)
Dermal neurological
electrical stimulation (n=22)
Chinese
electro-acupuncture (n=22)
Traditional Chinese
acupuncture together with
tricyclic antidepressants and
exercise (n=34)
Control intervention
Sham acupuncture (n=34)
Sham acupuncture (n=25)
Nontraditional site with
stimulation (n=28)
Nontraditional site with
no stimulation (n=27)
Amitriptyline (n=28)
Amitriptyline (n=19)
Fluoxetine (n=35)
Amitriptyline together
with Oryzanol and
Vitamin B1 (n=28)
Amitriptyline (n=22)
Amitriptyline (n=22)
tricyclic antidepressants
and exercise (n=24)
Course of treatment
3 weeks (2 treatment/week)
4, 28 weeks (1 treatment/2
to 4 days during 2 to 3
weeks)
- 3 weeks: 1 treatment/week
- 3 weeks: 2 treatment/week
- 3 weeks: 3 treatment/week
20 days
4 weeks
4 weeks
4 weeks
45 days
12, 24, 48, 96 weeks (2
treatment/week)
Main outcome
- VAS
- PPT
- FIQ
- MPI
- NRS (pain intensity)
- MFI (fatigue)
- SF-36 (PF)
- VAS
- VAS
- TePsN
- Total efficiency
- VAS
- TePsN
- Total efficiency
- MPQ (PRI, PPI)
- Total efficiency
- Total efficiency
- VAS
- TePsN
- PPT
- SF-36 (PF, RP, BP,
GH, VT, SF, RE, MH)
Table 1 Main study characteristics
Notes: a/b: one article includes two different trials. VAS: visual analogue scale; PPT: pressure pain threshold; FIQ: fibromyalgia impact
questionnaire; MPI: multidisciplinary pain inventory; NRS: numerical rating scale; MFI: multi-dimensional fatigue inventory; SF-36:
short-form health survey (PF: physical functioning, RP: role physical, BP: bodily pain, GH: general health, VT: vitality, SF: social func-
tioning, RE: role emotional, MH: mental health); TePsN: the number of tender points; TDP: specific electromagnetic spectrum treatment
device; MPQ: McGill pain questionnaire (PRI: pain rating index, PPI: present pain intensity).
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Study
Martin DP
et al 200625
Harria RE
et al 2005a/b26
Wang CM 200827
Guo AS
et al 200528
Guo Y
et al 201029
Wang SP
et al 200230
Guo XJ
et al 2004a/b31
Targino RA
et al 200832
Acupuncture points
Hegu (LI 4), Zusanli (ST 36), Xingjian (LR 2),
Sanyinjiao (SP 6), Shenmen (HT 7)
Baihui (GV 20), Shangyang (LI 11), Hegu (LI 4),
Yanglingquan (GB 34), Zusanli (ST 36), Sanyinjiao (SP
6), Sanjian (LI 3)
Ahshi-point
Points of Governor Vessel, Urinary Bladder Meridian of
Foot-Taiyang, the first and second lateral line
Ahshi-point
Adjunct points: Pishu (BL 20), Weishu (BL 21), Zusanli
(ST 36), Hegu (LI 4), Jiexi (ST 41), Quchi (LI 11),
Sanyinjiao (SP 6), Guanyuan (CV 4), Shenshu (BL 23),
Shenmen (HT 7), Geshu (BL 17), Fengmen (BL 12),
Waiguan (TE 5), Taichong (LR 3)
Ahshi-point
Shaoshang (LU 11), Taiyuan (LU 9), Shangyang (LI 1),
Sanjian (LI 3)
Main point: Fenchi (GB 20), Jianjing (GB 21), Xinshu
(BL 15), Dushu (BL 16), Geshu (BL 17), Zhibian (BL
54), Huantiao (GB 30), Huiyang (BL 35), Quchi (LI
11), Ququan (LR 8), Kufang (ST 15), Wuyi (ST 14)
Adjunct points: Taixi (KI 3), Shenmen (HT 7), Zusanli
(ST 36), Neiguan (PC 6)
Hegu (LI 4), Zusanli (ST 36), Xingjian (LR 2),
Sanyinjiao (SP 6), Neiguan (PC 6), Yanglingquan (GB
34)
Rationale for selection
of acupuncture points
Acupuncture literature
TCM theory
TCM theory
Clinical experience
TCM theory
Clinical experience
TCM theory
TCM theory
TCM theory
TCM theory
Adverse event
None (+)
Mild bruising and soreness
Mild vasovagal symptoms
Not mentioned
Not mentioned
Palpitation 0/6 (treatment
group/control group)
Mouth dryness 0/8
Dizziness 0/4
Perspiration 0/5
In appetence 0/4
Constipation 0/2
Not mentioned
Not mentioned
Not mentioned
Notes: a/b: one article includes two different trials. TCM: Traditional Chinese Medicine.
Table 2 Summary of treatment acupuncture points and rationale for selection of acupuncture points
Adequate sequence generation?
Allocation concealment?
Blinding?
Incomplete outcome data addresses?
Free of selective reporting?
Free of other bias?
0% 25% 50% 75% 100%
Yes (low risk of bias) Unclear No (high risk of bias)
Figure 2 Each methodological quality item presented as percentages across all included studies
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Incomplete outcome data addresses?
Free of selective reporting?
Free of other bias?
Figure 3 Each risk of bias domain for each included study
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come after 45 days of treatment. Their combined re-
sults showed that the two groups had statistically signif-
icant differences for total efficacy [RR=1.43, 95% CI
(1.16, 1.76), Chi2=0.03, I2=0%]. One trial29 compared
the efficacy of acupuncture with fluoxetine after 4
weeks of treatment, and the results showed that the
two groups had statistically significant differences for
total efficacy [RR=1.60, 95% CI (1.18, 2.17)]. One tri-
al30 compared the efficacy of acupuncture with amitrip-
tyline, oryzanol and vitamin B after 4 weeks of treat-
ment, and the results showed that the two groups had
a statistically significant difference [RR=1.50, 95% CI
(1.13, 1.99)] (Figure 6).
Acupuncture, drugs and exercise vs Western
Medicine and exercise
Only one trial32 compared the efficacy of acupuncture,
antidepressants and exercise with antidepressants and
exercise. In this study, only the PPT scores were ana-
lyzed and the results showed a statistically significant
difference in both the first 3 months [WMD=0.69,
95% CI (0.38, 1.00)] and 6 months [WMD=0.57,
95% CI (0.25, 0.89)]. There was no statistically signifi-
cant difference on follow-ups in months 12 and 24
(Figure 7).
Risk of bias across studies and additional analyses
Subgroup analysis. Comparing acupuncture with sham
acupuncture, there were significant effects on the MPI
and FIQ scores after 4 weeks of acupuncture treat-
ment; however, there were no effects on MPI and FIQ
scores after 7 weeks of acupuncture treatment. Com-
paring acupuncture with Western Medicine (amitripty-
lin): after 4 weeks of acupuncture treatment there were
no effects on total efficacy; however, after 45 days,
there were significant effects.
Figure 4 Meta-analysis of efficacy on acupuncture vs sham acupuncture by numerical rating scale
Figure 5 Meta-analysis of efficacy on acupuncture vs drugs by visual analogue scale
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Sensitivity Analysis. There was no significant heteroge-
neity in the NRS scale evaluation outcomes in weeks 3,
8 and 13. Because of the limited number of studies,
the potential sources of heterogeneity could not be as-
sessed.
Publication bias. Because less than 10 studies were ana-
lyzed, a visual inspection of funnel plots for indicators
of publication bias was not undertaken.
Dealing with missing data. The VAS, TePsN, and
SF-36 data in one trial32 were all median, and it was
Figure 7 Meta-analysis of efficacy on acupuncture + drugs+ exercise vs drugs + exercise by pressure pain threshold
Figure 6 Meta-analysis of efficacy on acupuncture vs drugs by total efficacy rate
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not possible to establish the original data or to deter-
mine whether it was a normal distribution, thus the
median was not equivalent to the mean. Only the PPT
scores were analyzed in this case.
DISCUSSION
Summary of evidence
In conclusion, there was not sufficient evidence to
prove that acupuncture had advantages in the treat-
ment of FMS compared with sham acupuncture. How-
ever, for pain relief and reducing the number of tender
points, acupuncture proved superior to drugs. Because
of the high risk of bias from low-quality literature,
high quality RCT trials are needed to support the con-
clusion. Moreover, there is evidence that pain thresh-
olds can increase with a combination of acupuncture,
Western Medicine and exercise in the short run (3-6
months), but there was no evidence of advantages in
the long run follow-up period (12-24 months).
Methodological strengths and limitations of included
trials
Comparing acupuncture with antidepressant was un-
dertaken in five clinical trials in China but without for-
eign reports. Meta-analysis results have shown the supe-
riority of acupuncture in the treatment of FMS. How-
ever, measurement bias was likely as there was no allo-
cation concealment or blinding in the included re-
search. Moreover, there was a baseline imbalance be-
cause of the selection bias led by quasi-randomized con-
trol trials in some included trials.28-30 It was not possible
to increase test efficiency by less combined data. The
blinding method was one of the 22 recommended
items in the CONSORT statement;33 however, it was
difficult to implement because of the strong operability
of acupuncture. This is also one of the reasons for the
low-quality of acupuncture literature. Therefore, the
present authors stress the importance of double-blind-
ing for the trial subject and outcome operator and of
blind assessment in blind acupuncture trials.34,35 For in-
stance, researchers could blindfold patients and pre-
vent the trial subject from talking with others who
have accepted the acupuncture therapy to implement
blinding and reduce the risk of bias.25,26 With regard to
measuring the total effective rate, the trials applied var-
ied measurement standards without clear sources lead-
ing to weak powers of test and specificity. Thus, the au-
thenticity of the results needs to be proved by further
rigorous clinical trials.
Despite the methodology limitations, the superiority
of acupuncture in the treatment of FMS cannot be de-
nied. A systematic review36 of a RCT trial comparing
amitriptyline and sham acupuncture suggested statisti-
cal significance after a 6-8 week period of taking drugs
in the aspect of relieving pain and fatigue; however, no
significance in week 12 revealed the short-lived superi-
ority of amitriptyline. The present findings suggested
that acupuncture was superior to amitriptyline on days
20, 28 and 45, further certifying the superiority of acu-
puncture.
Four of the trials24,25,26a/b comparing acupuncture and
sham acupuncture had a high methodological quality;
however, three24,26a/b chose points away from the verum
acupoint for the sham acupuncture group and had a
negative result. The authors of this current paper con-
sider this to be incorrect because (a) they may have
punctured other meridians or acupoints and thus gen-
erated certain therapeutic effects, (b) it is difficult to
find a true ineffective acupoint,37 (c) the width of the
meridians was unclear, thus whether the sham acu-
point was on the verum meridian could not be estab-
lished, and (d) it was not possible to establish if the
acupoints chosen in the trials were of superior efficien-
cy because there is a lack of generally accepted superior
acupoint groups. In addition, the Meta-analysis re-
vealed a general trend: there was statistical significance
in the VAS, FIQ, and MPI scales in weeks 3 and 4,
but this became negative after week 4. Therefore, there
is a need to establish if this difference was caused by
the effect of acupuncture or the scales on their own.
Aerobic exercise and anti-depressant drug recommend-
ed by American Pain Society was the evidence-based
A-level while acupuncture was C-level.38 However, in
one trial32 the effect of acupuncture was prominent
when the acupuncture, aerobic exercise and anti-de-
pressant drug therapies were integrated, particularly in
the third month. Although blinding and allocation
concealment were not described in the trial, acupunc-
ture would be the main therapy rather than other thera-
pies with its increasing therapeutic effect if the integrat-
ed therapy was proven by more trials.39
In addition, the advantage of using acupuncture to
treat FMS was the low number of side effects. Three
RCTs25,26,29 assessed the adverse events of acupuncture
treatment. Acupuncture side effects were mild26 and in-
frequent25 compared with sham acupuncture, and
when compared with drug treatment, no severe adverse
acupuncture effects were noted.29 Applying acupunc-
ture for the management of FMS might result in fewer
adverse effects than drug treatments.
Limitations of the systematic review and
Meta-analysis
The Chinese literature included in this systematic re-
view was of a generally low quality and there was a
high risk of bias from some of the quasi-randomized
control trials. Moreover, a small sample had a high bias
potential owing to the effect of certain elements. A fo-
cus on subgroup analysis, less combined data, and
weak test power were likely to generate false positive
conclusions. Therefore conclusions should be treated
cautiously. Moreover, there was a certain clinical het-
erogeneity because of differences in acupoint applica-
tion, course of treatment, course of disease, and age, as
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well as in EA and acupuncture. Having searched the re-
lated literature published in China and abroad, the
present authors still cannot eliminate the potential of
publication bias.
Conclusion and future research
Acupuncture has a good short-run therapeutic effect in
treating FMS that is maintained for 1-3 months, with
the first month having the best therapeutic effect.
Therefore, the treatment of a patient with FMS for 1
month with acupuncture in conjunction with an an-
ti-depressant drug and exercise therapy is recommend-
ed as the most favorable therapeutic effect.
In future research, the gold standard for acupoint selec-
tion rather than personal experiences, as well rigorous
trials of equivalence or non-inferiority in comparison
with Western Medicine should be first sought. A fur-
ther research direction is the integration of acupunc-
ture and Western Medicine such as an optimal selec-
tion of Western Medicine, acupoint selection and treat-
ment course. Appropriate sham acupuncture and
non-therapeutic or ineffective acupoints should be ex-
plored for placebos. Given that acupuncture works by
different acupoint groupings (or prescriptions) to treat
diseases, it should therefore be described as effective or
ineffective that certain groups of acupoints contrast cer-
tain intervention measures. Thus, the single word 'acu-
puncture' is not recommended in the treatment of
FMS.
Acupuncture is increasingly used as a traditional thera-
py in western countries to treat musculoskeletal dis-
ease.40 We suggest that the diagnostic criteria proposed
by the ACR in 201041 should be adopted in future re-
search. Moreover, based on the CONSORT State-
ment, a rigorously designed multi-center RCT and a
large practical sample should be implemented to assess
the clinical therapeutic effect of FMS by acupuncture
therapy.
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